Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jvs.2007.03.033 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Remodeling in peripheral vein graft revisions: serial study with three-dimensional ultrasound imaging.
J Vasc Surg
April 2003
Department of Surgery, University of Washington, Seattle, 98195, USA.
Objective: Remodeling of vein grafts in the lower limb can lead to stenotic lesions that threaten long-term graft patency. Progressive changes in vein graft geometry were measured at sites of repaired stenoses with three-dimensional (3D) ultrasound imaging.
Methods: Ten vein graft revisions with patch angioplasty were followed up for 31 to 47 weeks.
A survey of physicians' knowledge and management of venous thromboembolism.
Vasc Endovascular Surg
December 2002
Department of Biobehavioral Nursing, University of Washington School of Nursing and School of Medicine, Seattle, WA, USA.
A review of all patients diagnosed with venous thromboembolism (VTE) at an academic medical center from 1996 to 1998 revealed a wide variation in management and subsequent patient outcomes and a 30% increase in utilization of the vascular laboratory from the previous 2-year period. The purpose of this study was to determine physicians' knowledge and management strategies before the implementation of integrated care pathways for VTE. Mail surveys were sent to 650 physicians covering 3 academic medical centers.
View Article and Find Full Text PDFEffect of cilostazol in patients with intermittent claudication: a randomized, double-blind, placebo-controlled study.
Vasc Endovascular Surg
May 2002
University of Washington Medical Center, Seattle, WA, USA.
A multicenter, double-blind, randomized, placebo-controlled, parallel study was conducted to compare the efficacy and safety of cilostazol 100 mg and 50 mg, both administered twice daily, with that of placebo in patients with moderately severe intermittent claudication (IC) secondary to peripheral arterial disease.A total of 394 subjects 40 years of age or older with chronic, stable, symptomatic IC received cilostazol 100 mg twice daily, 50 mg twice daily, or placebo for 24 weeks. Subjects receiving cilostazol 100 mg twice daily experienced a 21% net improvement in maximal walking distance (MWD)compared with placebo subjects (p = 0.
View Article and Find Full Text PDFCoagulation, fibrinolysis, and recanalization after acute deep venous thrombosis.
J Vasc Surg
February 2002
Department of Surgery, University of Washington School of Medicine, Seattle, USA.
Objective: Recanalization is common after acute deep venous thrombosis, but the factors that contribute to its variable extent are unknown. The purpose of this study was to examine the relationship between recanalization and plasma markers of coagulation and fibrinolysis.
Methods: Subjects with an ultrasound-confirmed deep venous thrombosis had prothrombin fragment 1+2 (F 1+2), tissue plasminogen activator (t-PA) activity, plasminogen activator inhibitor (PAI-1) activity, and t-PA antigen levels determined before anticoagulation therapy.